241 related articles for article (PubMed ID: 11376123)
21. Signaling differences from the A and B isoforms of the insulin receptor (IR) in 32D cells in the presence or absence of IR substrate-1.
Sciacca L; Prisco M; Wu A; Belfiore A; Vigneri R; Baserga R
Endocrinology; 2003 Jun; 144(6):2650-8. PubMed ID: 12746329
[TBL] [Abstract][Full Text] [Related]
22. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
[TBL] [Abstract][Full Text] [Related]
23. An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis.
Alexia C; Fallot G; Lasfer M; Schweizer-Groyer G; Groyer A
Biochem Pharmacol; 2004 Sep; 68(6):1003-15. PubMed ID: 15313394
[TBL] [Abstract][Full Text] [Related]
24. Activation of the insulin-like growth factor 1 signaling pathway by the antiapoptotic agents aurintricarboxylic acid and evans blue.
Beery R; Haimsohn M; Wertheim N; Hemi R; Nir U; Karasik A; Kanety H; Geier A
Endocrinology; 2001 Jul; 142(7):3098-107. PubMed ID: 11416032
[TBL] [Abstract][Full Text] [Related]
25. Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity.
Rubin R; Baserga R
Lab Invest; 1995 Sep; 73(3):311-31. PubMed ID: 7564264
[TBL] [Abstract][Full Text] [Related]
26. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
27. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor.
Hongo A; D'Ambrosio C; Miura M; Morrione A; Baserga R
Oncogene; 1996 Mar; 12(6):1231-8. PubMed ID: 8649825
[TBL] [Abstract][Full Text] [Related]
28. Membrane rafts segregate pro- from anti-apoptotic insulin-like growth factor-I receptor signaling in colon carcinoma cells stimulated by members of the tumor necrosis factor superfamily.
Remacle-Bonnet M; Garrouste F; Baillat G; Andre F; Marvaldi J; Pommier G
Am J Pathol; 2005 Sep; 167(3):761-73. PubMed ID: 16127155
[TBL] [Abstract][Full Text] [Related]
29. The role of the insulin receptor substrate-1 in the differentiation of rat hippocampal neuronal cells.
Morrione A; Navarro M; Romano G; Dews M; Reiss K; Valentinis B; Belletti B; Baserga R
Oncogene; 2001 Aug; 20(35):4842-52. PubMed ID: 11521195
[TBL] [Abstract][Full Text] [Related]
30. PI3K-p110-alpha-subtype signalling mediates survival, proliferation and neurogenesis of cortical progenitor cells via activation of mTORC2.
Wahane SD; Hellbach N; Prentzell MT; Weise SC; Vezzali R; Kreutz C; Timmer J; Krieglstein K; Thedieck K; Vogel T
J Neurochem; 2014 Jul; 130(2):255-67. PubMed ID: 24645666
[TBL] [Abstract][Full Text] [Related]
31. Insulin receptor substrate (IRS)-1 regulates murine embryonic stem (mES) cells self-renewal.
Rubin R; Arzumanyan A; Soliera AR; Ross B; Peruzzi F; Prisco M
J Cell Physiol; 2007 Nov; 213(2):445-53. PubMed ID: 17620314
[TBL] [Abstract][Full Text] [Related]
32. Insulin-like growth factor I receptor signaling in differentiation of neuronal H19-7 cells.
Morrione A; Romano G; Navarro M; Reiss K; Valentinis B; Dews M; Eves E; Rosner MR; Baserga R
Cancer Res; 2000 Apr; 60(8):2263-72. PubMed ID: 10786694
[TBL] [Abstract][Full Text] [Related]
33. Dissociation between resistance to apoptosis and the transformed phenotype in IGF-I receptor signaling.
Romano G; Prisco M; Zanocco-Marani T; Peruzzi F; Valentinis B; Baserga R
J Cell Biochem; 1999 Feb; 72(2):294-310. PubMed ID: 10022512
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor I receptor signaling and nuclear translocation of insulin receptor substrates 1 and 2.
Sun H; Tu X; Prisco M; Wu A; Casiburi I; Baserga R
Mol Endocrinol; 2003 Mar; 17(3):472-86. PubMed ID: 12554758
[TBL] [Abstract][Full Text] [Related]
35. Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway.
Doepfner KT; Spertini O; Arcaro A
Leukemia; 2007 Sep; 21(9):1921-30. PubMed ID: 17581609
[TBL] [Abstract][Full Text] [Related]
36. The role of insulin-like growth factor I and its receptor in cell growth, transformation, apoptosis, and chemoresistance in solid tumors.
Grothey A; Voigt W; Schöber C; Müller T; Dempke W; Schmoll HJ
J Cancer Res Clin Oncol; 1999; 125(3-4):166-73. PubMed ID: 10235470
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase.
Dunn SE; Torres JV; Oh JS; Cykert DM; Barrett JC
Cancer Res; 2001 Feb; 61(4):1367-74. PubMed ID: 11245436
[TBL] [Abstract][Full Text] [Related]
38. Insulin-like growth factor-I signaling in human neuroblastoma cells.
Kim B; van Golen CM; Feldman EL
Oncogene; 2004 Jan; 23(1):130-41. PubMed ID: 14712218
[TBL] [Abstract][Full Text] [Related]
39. Differential requirements of the MAP kinase and PI3 kinase signaling pathways in Src- versus insulin and IGF-1 receptors-induced growth and transformation of rat intestinal epithelial cells.
Nguyen KT; Wang WJ; Chan JL; Wang LH
Oncogene; 2000 Nov; 19(47):5385-97. PubMed ID: 11103940
[TBL] [Abstract][Full Text] [Related]
40. Caveolin-1 down-regulation inhibits insulin-like growth factor-I receptor signal transduction in H9C2 rat cardiomyoblasts.
Salani B; Briatore L; Garibaldi S; Cordera R; Maggi D
Endocrinology; 2008 Feb; 149(2):461-5. PubMed ID: 18039791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
